期刊
CYTOTHERAPY
卷 18, 期 12, 页码 1471-1475出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.jcyt.2016.08.005
关键词
ALS; clinical trials; stem cells; transplantation
类别
资金
- Uniti Ricerca Sclerosi Larerale Amiotrofica (URSLA)-Novara Onlus Association
Intraspinal stem cell (SC) transplantation represents a new therapeutic approach for amyotrophic lateral sclerosis (ALS) clinical trials. There are considerable difficulties in designing future efficacy trials, some related to the field of ALS and some that are specific to SCs or the mode of delivery. In October 2015, the most controversial points on SC transplantation were addressed during an international workshop intended to bring together international SC and ALS researchers in a public discussion on a topic for which expertise is limited. During the meeting, a discussion was started on the basic structure of the ideal clinical trial testing the efficacy and safety of SC transplantation. The current document includes a number of consensus points reflecting the design of phase II/III clinical trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据